Pfizer is one of the most recognized names in pharmaceuticals. Muslim investors often wonder if it's halal, especially since making medicines seems like a permissible business. The verdict from Zoya's AAOIFI-based screening: Pfizer is not Shariah-compliant.
The issue with Pfizer isn't what it makes. Pharmaceuticals are generally a permissible business under Islamic law. The problem is how Pfizer is financed. Its debt-to-total-assets ratio exceeds the 33% threshold set by AAOIFI guidelines, which makes it non-compliant for Muslim investors regardless of the underlying business.
Ready to compare halal options?
What is Pfizer?
Pfizer is a global biopharmaceutical company with approximately $62.6 billion in annual revenue. Its product portfolio spans cardiovascular treatments, infectious diseases, COVID-19 therapies, oncology, and rare diseases. It's one of the largest pharmaceutical companies in the world by revenue and market cap.
The company has made major acquisitions in recent years, including the $43 billion purchase of Seagen, an oncology-focused biotech. Large acquisitions funded by debt are common in pharma. They also directly impact Shariah compliance screening because they add significant interest-bearing liabilities to the balance sheet.
How Zoya screens Pfizer for Shariah compliance
Zoya applies AAOIFI methodology with two stages. The first is the business activity screen, which checks whether a company's core operations involve prohibited activities like alcohol, gambling, conventional banking, tobacco, or weapons. Pharmaceuticals pass this screen. Making medicines to treat illness is permissible.
The second stage is the financial ratio screen. AAOIFI sets a maximum debt-to-total-assets ratio of 33%. It also caps interest income at 5% of total revenue. These thresholds exist because a company with a permissible business can still be problematic if it's heavily financed through interest-bearing instruments, which generates and circulates riba through the financial system.
Pfizer's interest income sits at roughly 0.96% of revenue, which is within the 5% limit on its own. But the debt ratio is where Pfizer fails. Large pharma companies routinely borrow to fund R&D and acquisitions, and Pfizer's debt structure pushes it past the AAOIFI threshold.
Why Pfizer fails Shariah screening
Pfizer's primary compliance issue is its leverage. The debt-to-total-assets ratio exceeds AAOIFI's 33% ceiling. This is common among large pharmaceutical companies that finance billion-dollar drug development programs and acquisitions through bond issuances and revolving credit facilities, all of which carry interest.
The Seagen acquisition alone added tens of billions in liabilities. When debt-funded acquisitions push total debt past a third of total assets, the stock fails AAOIFI screening, period. The underlying business being permissible doesn't change the financial screen outcome.
It's worth understanding that AAOIFI's financial screens aren't arbitrary. They reflect a principle: if a company relies heavily on interest-based financing to operate, an investor's capital is indirectly participating in that interest-based structure. The 33% threshold is where AAOIFI draws the line.
What should Muslim investors do?
As long as Pfizer's debt ratio remains above the AAOIFI threshold, you can't hold it in a halal portfolio. Check its status periodically in Zoya; if Pfizer reduces its debt load significantly, compliance could change.
Top Providers for This Topic
Free to compare · No sign-up required
If you want pharmaceutical or healthcare exposure, Johnson & Johnson is a compliant alternative in the same sector. JNJ carries interest income of around 0.09% of revenue and its debt ratios fall within AAOIFI thresholds. You can read more about that in the halal stocks overview on HalalWallet's investing hub.
For broad exposure without stock-picking, halal ETFs like SPUS and HLAL hold a diversified mix of compliant companies. Healthcare names that clear screening are included in their portfolios. This is a lower-maintenance approach if you don't want to monitor individual financials each quarter. You can learn how to start investing halal with $500 to see how ETFs fit into a beginner halal portfolio.
Bottom line
Pfizer fails Shariah screening under AAOIFI guidelines because of its debt structure. The core pharmaceutical business is permissible, but the financial ratios don't pass. For Muslim investors, Pfizer is off the table until its balance sheet changes. Consider JNJ for halal healthcare exposure, or use a halal ETF for diversified market access.
Before buying any stock, run it through Zoya and check the current status. You can also compare Zoya and Musaffa if you want to see how two major halal screening tools handle companies like Pfizer.
Frequently asked questions
Is making pharmaceuticals halal?
Yes, the pharmaceutical business itself is generally permissible in Islam. Treating illness and developing medicines is considered a beneficial activity. The issue with Pfizer isn't its products. It's the financial structure, specifically the level of interest-bearing debt on the balance sheet.
Could Pfizer become halal in the future?
Yes, if Pfizer pays down debt and reduces its total debt-to-assets ratio below 33%, it could pass AAOIFI screening. Shariah ratings are recalculated quarterly. Keep it on your watchlist in Zoya if you want to be notified if its status changes.
What is the AAOIFI debt threshold and why does it matter?
AAOIFI sets a 33% maximum ratio of interest-bearing debt to total assets. The logic is that if more than a third of a company's assets are funded through interest-based financing, the company's capital structure is too entangled with riba for a Muslim investor to be comfortable. The full explanation of these screens is in the what makes a stock halal guide.
Are there other compliant pharmaceutical stocks?
JNJ is the most prominent compliant large-cap healthcare name. Other pharma and biotech companies vary in their compliance. Use Zoya to screen any specific ticker before investing. The best halal stocks guide for 2026 also covers compliant options across multiple sectors.
Compare providers in your state
See side-by-side comparisons of Shariah-compliant products, or let our matcher recommend the best options for your situation.
Should I use a stock screener or a halal ETF for healthcare exposure?
Both approaches work. Individual stocks require quarterly monitoring. Halal ETFs like SPUS, HLAL, and MNZL are screened and rebalanced by the fund manager, which takes that burden off you. The tradeoff is that you own the whole portfolio, not just the healthcare names. For most investors who aren't doing deep sector bets, the ETF approach is simpler.
